These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M. Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307 [Abstract] [Full Text] [Related]
4. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies. Wang LQ, Liang R, Chim CS. Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241 [Abstract] [Full Text] [Related]
5. The miR-34 family in cancer and apoptosis. Hermeking H. Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653 [Abstract] [Full Text] [Related]
6. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643 [Abstract] [Full Text] [Related]
8. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Hummel R, Hussey DJ, Haier J. Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396 [Abstract] [Full Text] [Related]
9. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C. Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894 [Abstract] [Full Text] [Related]
10. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J. Cancer Res; 2011 Oct 15; 71(20):6450-62. PubMed ID: 21868754 [Abstract] [Full Text] [Related]
11. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. Xie K, Liu J, Chen J, Dong J, Ma H, Liu Y, Hu Z. Gene; 2014 Jun 10; 543(1):101-7. PubMed ID: 24704024 [Abstract] [Full Text] [Related]
12. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, Nasu Y, Kishimoto T, Pass HI, Matsui H, Huh NH, Miyoshi S. Clin Cancer Res; 2011 Aug 01; 17(15):4965-74. PubMed ID: 21673066 [Abstract] [Full Text] [Related]
13. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer. Endo H, Muramatsu T, Furuta M, Uzawa N, Pimkhaokham A, Amagasa T, Inazawa J, Kozaki K. Carcinogenesis; 2013 Mar 01; 34(3):560-9. PubMed ID: 23233740 [Abstract] [Full Text] [Related]
14. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. Cancer Res; 2007 Sep 15; 67(18):8433-8. PubMed ID: 17823410 [Abstract] [Full Text] [Related]
19. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y. Carcinogenesis; 2010 Dec 15; 31(12):2066-73. PubMed ID: 20924086 [Abstract] [Full Text] [Related]
20. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. Chen F, Hu SJ. J Biochem Mol Toxicol; 2012 Feb 15; 26(2):79-86. PubMed ID: 22162084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]